D-0750-2021 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0750-2021 was initiated by Dr. Reddy's Laboratories, Inc. on Jul 19, 2021 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specification: Some tablets are shaved The recall status is terminated (terminated Dec 21, 2022). Affected quantity: 37560 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 25, 2021
Initiation Date
Jul 19, 2021
Termination Date
Dec 21, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
37560 bottles

Product description

Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15.

Reason for recall

Failed Tablet/Capsule Specification: Some tablets are shaved

Distribution pattern

Nationwide within the United States

Code information

Lot #: T2000471, exp date 09/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0750-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0750-2021. Report a data issue: hello@regdatalab.com.